Skip to content

Combined Anesthesia for Laparoscopy Surgery in Gynecology

Combined General and Spinal Anesthesia vs. General Anesthesia for Pain Relief During Laparoscopy Gynecological Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01246323
Enrollment
40
Registered
2010-11-23
Start date
2010-11-30
Completion date
2012-12-31
Last updated
2011-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Visual analogue scale, pain level, analgesia, combined anesthesia

Brief summary

The purpose of this study is to determine whether combined anesthesia will provide better pain control for the postoperative period following gynecological laparoscopy surgery.

Detailed description

Following signing an informed consent patients who are scheduled for gynecological laparoscopy surgery for benign disease will randomized to general vs. combined general and spinal anesthesia. During the postoperative period data regarding pain level as evaluated by visual analogue scale (VAS), number of doses of pain relief drugs, satisfaction and number of day in hospitalization will be collected from patient charts.

Interventions

PROCEDURESpinal anesthesia with Fentanyl+ Morphine

Fentanyl 15 microgram Morphine 0.1-0.5 mg

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. American Society of Anesthesiology (ASA) physical status classification system:ASA I-III. 2. Benign Gynecological Laparoscopy surgery

Exclusion criteria

1. Patients who are not capable to sign the consent form. 2. Women with known allergy to the medication used in spinal analgesia. 3. Patients who are pregnant or lactating. 4. Patients with contraindication to spinal analgesia. 5. Patients who use opioid on a regular base.

Design outcomes

Primary

MeasureTime frameDescription
Pain levelFor the first 72 hours following surgeryPain level will be evaluated every 4 hours from the time of surgery to discharge
Number of doses of analgesic drugsFor the first 72 hours following surgeryNumber of doses of analgesic medications will be collected from patients charts.

Countries

Israel

Contacts

Primary ContactLior Lowenstein, MD, MS
LowensteinMD@gmail.com050-2061434

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026